Literature DB >> 7041663

Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms.

W A Krotoski, R S Bray, P C Garnham, R W Gwadz, R Killick-Kendrick, C C Draper, G A Targett, D M Krotoski, M W Guy, L C Koontz, F B Cogswell.   

Abstract

Confirmation of the existence of a persistent, uninucleate, dormant pre-erythrocytic stage, the hypnozoite, of the relapsing simian malaria parasite, Plasmodium cynomolgi bastianellii, has been obtained by means of experiments involving the intravenous injection into susceptible monkeys of 48 to 85 x 10(6) sporozoites derived from mosquitoes of a different species and source than employed previously. The development of these hypnozoites was traced from 3 days until 105 days after sporozoite inoculation, employing a sensitive immunofluorescence technique followed by restaining with Giemsa. From an average mean diameter of 4 micrometers at 3 and 5 days, uninucleate hypnozoites grow to 5 micrometers at 7 days, then persist with little change until at least 105 days after infection. Strong evidence for the viability of these persistent forms was obtained by treatment of a host monkey with primaquine, which eliminated all trace of hypnozoites present 2 weeks before. Examination of hepatic tissue from a monkey injected with sporozoites 36 and 40 hours earlier revealed rare uninucleate pre-erythrocytic forms of 2.5-micrometers diameter. These early forms were present in hepatocytes in a density only approximately 1/30th of that expected on the basis of numbers of pre-erythrocytic stages found in the same animal's liver 7 days after infection. Nevertheless, subinoculation experiments appeared to rule out the circulation as a vehicle for dissemination of any putative early intermediate hepatotropic forms from another site.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041663

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.

Authors:  Gregory A Deye; Montip Gettayacamin; Pranee Hansukjariya; Rawiwan Im-erbsin; Jetsumon Sattabongkot; Yarrow Rothstein; Louis Macareo; Susan Fracisco; Kent Bennett; Alan J Magill; Colin Ohrt
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

Review 2.  What is the evidence for the existence of Plasmodium ovale hypnozoites?

Authors:  Joachim Richter; Gabriele Franken; Heinz Mehlhorn; Alfons Labisch; Dieter Häussinger
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

Review 3.  The hypnozoite concept, with particular reference to malaria.

Authors:  Miles B Markus
Journal:  Parasitol Res       Date:  2010-10-06       Impact factor: 2.289

4.  The painstaking discovery of the hidden face of the human plasmodia.

Authors:  Jean-François Pays
Journal:  Parasitol Res       Date:  2012-05-18       Impact factor: 2.289

Review 5.  Current therapies and future possibilities for drug development against liver-stage malaria.

Authors:  Rene Raphemot; Dora Posfai; Emily R Derbyshire
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

6.  Transformation of sporozoites of Plasmodium berghei into exoerythrocytic forms in the liver of its mammalian host.

Authors:  J F Meis; J P Verhave; P H Jap; J H Meuwissen
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

Review 7.  The biology of tissue forms and other asexual stages in mammalian plasmodia.

Authors:  J P Verhave; J F Meis
Journal:  Experientia       Date:  1984-12-15

8.  Characterizing the genetic diversity of the monkey malaria parasite Plasmodium cynomolgi.

Authors:  Patrick L Sutton; Zunping Luo; Paul C S Divis; Volney K Friedrich; David J Conway; Balbir Singh; John W Barnwell; Jane M Carlton; Steven A Sullivan
Journal:  Infect Genet Evol       Date:  2016-03-14       Impact factor: 3.342

9.  Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.

Authors:  Rie Takeuchi; Saranath Lawpoolsri; Mallika Imwong; Jun Kobayashi; Jaranit Kaewkungwal; Sasithon Pukrittayakamee; Supalap Puangsa-art; Nipon Thanyavanich; Wanchai Maneeboonyang; Nicholas P J Day; Pratap Singhasivanon
Journal:  Malar J       Date:  2010-11-01       Impact factor: 2.979

Review 10.  The hypnozoite and relapse in primate malaria.

Authors:  F B Cogswell
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.